chr17-39605644-T-G

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4

The NM_006160.4(NEUROD2):​c.956A>C​(p.His319Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H319R) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)

Consequence

NEUROD2
NM_006160.4 missense

Scores

1
8
9

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 2.10

Publications

0 publications found
Variant links:
Genes affected
NEUROD2 (HGNC:7763): (neuronal differentiation 2) This gene encodes a member of the neuroD family of neurogenic basic helix-loop-helix (bHLH) proteins. Expression of this gene can induce transcription from neuron-specific promoters, such as the GAP-43 promoter, which contain a specific DNA sequence known as an E-box. The product of the human gene can induce neurogenic differentiation in non-neuronal cells in Xenopus embryos, and is thought to play a role in the determination and maintenance of neuronal cell fates. [provided by RefSeq, Jul 2008]
NEUROD2 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 72
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.38862985).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006160.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NEUROD2
NM_006160.4
MANE Select
c.956A>Cp.His319Pro
missense
Exon 2 of 2NP_006151.3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NEUROD2
ENST00000302584.5
TSL:1 MANE Select
c.956A>Cp.His319Pro
missense
Exon 2 of 2ENSP00000306754.4Q15784
NEUROD2
ENST00000907630.1
c.956A>Cp.His319Pro
missense
Exon 2 of 2ENSP00000577689.1
NEUROD2
ENST00000907631.1
c.956A>Cp.His319Pro
missense
Exon 2 of 2ENSP00000577690.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.099
BayesDel_addAF
Uncertain
0.15
D
BayesDel_noAF
Uncertain
-0.030
CADD
Uncertain
23
DANN
Benign
0.89
DEOGEN2
Uncertain
0.42
T
Eigen
Benign
-0.15
Eigen_PC
Benign
-0.055
FATHMM_MKL
Uncertain
0.83
D
LIST_S2
Benign
0.35
T
M_CAP
Pathogenic
0.70
D
MetaRNN
Benign
0.39
T
MetaSVM
Uncertain
0.49
D
MutationAssessor
Benign
1.1
L
PhyloP100
2.1
PrimateAI
Uncertain
0.63
T
PROVEAN
Uncertain
-3.0
D
REVEL
Uncertain
0.45
Sift
Benign
0.14
T
Sift4G
Benign
0.085
T
Polyphen
0.57
P
Vest4
0.45
MutPred
0.19
Gain of glycosylation at H319 (P = 0.0898)
MVP
0.57
ClinPred
0.47
T
GERP RS
4.6
Varity_R
0.54
gMVP
0.60

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs778638603; hg19: chr17-37761897; API